Southern California Evidence Review Center, University of Southern California, Los Angeles, California, USA
Southern California Evidence Review Center, University of Southern California, Los Angeles, California, USA.
BMJ Open. 2023 Sep 22;13(9):e072098. doi: 10.1136/bmjopen-2023-072098.
Multiple chemical sensitivity (MCS) has been characterised by reported adverse responses to environmental exposures of common chemical agents (eg, perfumes, paint, cleaning products and other inhaled or ingested agents) in low doses considered non-toxic for the general population. There is currently no consensus on whether MCS can be established as a distinct disorder.
The scoping review of the literature will be guided by five questions: How is MCS defined and which diagnostic criteria have been proposed? What methods are used to report prevalence and incidence estimates of MCS? What are the characteristics of the body of scientific evidence that addresses whether MCS is a distinct disorder or syndrome? What underlying mechanisms for MCS have been proposed in the scientific literature? Which treatment and management approaches for MCS have been evaluated in empirical research studies? We will conduct a comprehensive search in 14 research databases. Citation screening will be supported by machine learning algorithms. Two independent reviewers will assess eligibility of full-text publications against prespecified criteria. Data abstraction will support concise evidence tables. A formal consultation exercise will elicit input regarding the review results and presentation. The existing research evidence will be documented in a user-friendly visualisation in the format of an evidence map.
Determined to be exempt from review (UP-22-00516). Results will be disseminated through a journal manuscript and data will be publicly accessible through an online data repository.
The protocol is registered in Open Science Framework (osf.io/4a3wu).
多种化学敏感性 (MCS) 的特征是报告对环境暴露于常见化学物质(例如香水、油漆、清洁产品和其他吸入或摄入的物质)的不良反应,这些暴露的剂量被认为对一般人群是无毒的。目前对于 MCS 是否可以被确定为一种独特的疾病还没有共识。
文献的范围审查将由五个问题指导:MCS 是如何定义的,提出了哪些诊断标准?用于报告 MCS 的患病率和发病率估计值的方法是什么?解决 MCS 是否为一种独特疾病或综合征的科学证据有哪些特点?科学文献中提出了哪些用于解释 MCS 的潜在机制?在实证研究中,已经评估了哪些用于治疗和管理 MCS 的方法?我们将在 14 个研究数据库中进行全面搜索。引文筛选将得到机器学习算法的支持。两名独立的审查员将根据预设标准评估全文出版物的资格。数据抽象将支持简洁的证据表。正式的咨询活动将征求有关审查结果和演示的意见。现有的研究证据将以证据图的形式以用户友好的可视化方式记录下来。
被确定为豁免审查(UP-22-00516)。结果将通过期刊手稿传播,数据将通过在线数据存储库公开获取。
该方案在开放科学框架 (osf.io/4a3wu) 中注册。